Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection Luis Figuero-Pérez; Alejandro Olivares-Hernández; Roberto A. Escala-Cornejo; Juan J. Cruz-Hernández;

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab Luis Figuero-Pérez; Alejandro Olivares-Hernández; Roberto A. Escala-Cornejo; Eduardo Terán-Brage; Álvaro López-Gutiérrez; Juan J. Cruz-Hernández;

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment Ismael Francisco Aomar-Millán; Juan Salvatierra; José Luis Callejas-Rubio; Enrique Raya-Álvarez;